Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05868044 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REsponse to Combined SONS and ONS in Chronic Cluster headachE

Study acronym: RESPONSE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion date: Apr 30, 2026 to Dec 30, 2026v6
  2. Trial status: Recruiting to Active, Not Recruiting Primary completion date changed from estimate of Sep 1, 2024 to Apr 23, 2024 · Site details revisedv5 Show 2 more changesShow less
    • Primary completion date changed from estimate of Sep 1, 2024 to Apr 23, 2024
    • Site details revised
  3. Re-verified, no change to tracked fieldsv4
  4. Primary completion date: May 1, 2024 to Sep 1, 2024 Completion date: Nov 30, 2024 to Apr 30, 2026v3 Show 1 more changeShow less
    • Completion date: Nov 30, 2024 to Apr 30, 2026
  5. Primary completion date: Oct 1, 2023 to May 1, 2024 Completion date: Jan 31, 2024 to Nov 30, 2024 · Eligibility criteria expanded, about 3 wordsv2 Show 2 more changesShow less
    • Completion date: Jan 31, 2024 to Nov 30, 2024
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to demonstrate the safe use of the PRIMUS System in subjects with chronic cluster headache. This is a single-centre, open label, prospective, first in human study to collect initial clinical data on the PRIMUS system for the treatment of chronic cluster headache.
Trial Details
NCT Number NCT05868044
Lead Sponsor Salvia BioElectronics
Conditions Chronic Cluster Headache
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov